Use of Fomepizole in Pediatric Methanol Exposure: The First Case Report in Taiwan and a Literature Review  by Chen, Tzu-Hua et al.
Pediatrics and Neonatology (2016) 57, 351e354Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.pediatr -neonatol .comCASE REPORTUse of Fomepizole in Pediatric Methanol
Exposure: The First Case Report in Taiwan
and a Literature ReviewTzu-Hua Chen a,b, Chang-Hung Kuo c,d, Chia-Tsuan Huang a,c,e,
Wei-Li Wang c,f,g,*aDepartment of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
bDepartment of Family Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
cDepartment of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
dDepartment of Pediatrics, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
e School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
fDepartment of Emergency, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
gDepartment of Pediatrics, True Generation Hospital, Kaohsiung, TaiwanReceived Nov 4, 2012; received in revised form May 29, 2013; accepted Aug 8, 2013
Available online 11 December 2013Key Words
fomepizole;
methanol;
pediatric* Corresponding author. Departmen
Medical University Hospital, Number
Kaohsiung City 807, Taiwan.
E-mail address: fordrwang@yahoo.
http://dx.doi.org/10.1016/j.pedneo.2
1875-9572/Copyright ª 2013, Taiwan
CC BY-NC-ND license (http://creativeMethanol poisoning is rare in the pediatric population, but a delay in diagnosis and intervention
may cause severe morbidity and mortality. The current therapy for methanol poisoning is
ethanol or fomepizole, which acts as a competitive inhibitor of hepatic alcohol dehydrogenase
to inhibit the production of toxic metabolites derived from the oxidation of methanol. Howev-
er, clinical experience in pediatric methanol poisoning is limited, and the safety profiles of the
antidotes have not been established in children, especially in Asian populations. This is the first
case to describe the use of fomepizole in a child with methanol exposure in Taiwan.
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Methanol is commonly used in antifreezes, solvents, and
many other products. Methanol itself is not toxic, but it is
oxidized by hepatic alcohol dehydrogenase to formalde-
hyde and then oxidized to formic acid, which is responsibleby Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
352 T.-H. Chen et alfor metabolic acidosis and retinal toxicity.1 Even small
amounts of methanol ingestion may be fatal in children
without timely treatment.2 The traditional antidote is
ethanol, a competitive inhibitor of alcohol dehydrogenase,
to inhibit the metabolism of methanol. Fomepizole (4-
methylpyrazole), a more potent competitive inhibitor of
alcohol dehydrogenase, has been recommended as a su-
perior antidote due to higher efficacy and less adverse ef-
fects than ethanol.1 However, clinical experience of
fomepizole use in children is limited,3 and no cases have
been reported in Asian populations. Herein, we report a
case of pediatric methanol exposure with successful
treatment of fomepizole.2. Case Report
A 1-year, 5-month-old boy swallowed an unknown amount of
alcohol paste (contentZ 80%methanol), whichwas a type of
fuel of a chafing dish. He was sent to the emergency
department 50 minutes after ingestion. Initial vital signs
were stable. His consciousness was alert, but his activity was
mildly to moderately decreased. His body weight was 10 kg.
Physical and neurological examinations were normal. A
blood gas analysis was as follows: pH, 7.176; PCO2,
49.9 mmHg; PO2, 104.4 mmHg; and bicarbonate, 18mmol/L.
Biochemical analyses of plasma revealed the following: so-
dium, 138 mmol/L; potassium, 4.4 mmol/L; chloride,
108 mmol/L; lactate, 2.1 mmol/L; blood urea nitrogen,
6.7 mmol/L; creatinine, 23.0 mmol/L; and glucose,
4.8 mmol/L. Anion gap was 12 mEq/L. The measured serum
osmolality was 294 mOsm/kg, and the calculated serum os-
molarity was 288 mOsm/kg, yielding an osmolal gap of
6 mOsm/kg. Serum concentrations of methanol and ethanol
were measured, but the data could not be obtained
immediately.
Initially, we performed nasogastric irrigation and fed the
patient 45 cc of Shaoxing wine (content Z 17% ethanol),
and then we initiated fomepizole therapy. He received a
15 mg/kg loading dose of fomepizole and was then
admitted to the pediatric intensive care unit.
Five hours after the loading dose, arterial pH level was
7.354, and serum bicarbonate level was 21 mmol/L. We
continued to give him a 10 mg/kg maintenance dose of
fomepizole every 12 hours, and we also administratedFigure 1 (A) Level of arterial pH over time after methanol inges
ingestion.intravenous sodium bicarbonate to correct acidemia. Mea-
surement of arterial blood gas, electrolytes, blood urea
nitrogen, creatinine, glucose, and serum methanol con-
centration was followed up every 6 hours. Arterial pH and
serum bicarbonate levels over time are shown in Figure 1.
No visual deficits were found by the ophthalmologist on the
2nd day. After treatment, vital signs were stable, and no
additional acidemia was noted, thus we discontinued
fomepizole. He was transferred to the general pediatric
ward on the 4th day and discharged on the 5th day. We
obtained the following reports on the 9th day: serum con-
centration of methanol <0.1 mg/dL and ethanol <5 mg/dL
on arrival to the emergency department and subsequent
follow-up, respectively. No signs of methanol intoxication,
no visual deficits, and no adverse effects of fomepizole
were found at the outpatient department on the 10th day.3. Discussion
Methanol is absorbed rapidly by the gastrointestinal tract
and reaches peak concentration within 30e60 minutes.4
The typical signs and symptoms of methanol poisoning
include visual dysfunction, nausea, vomiting, abdominal
pain, and central nervous system depression, with a latent
period of 12e24 hours for methanol to oxidize to toxic
metabolites.2,4 Therefore, the antidotes should be admin-
istrated as soon as possible prior to formate formation, and
early treatment may prevent fatalities and the need for
hemodialysis.2,5 Serum methanol concentration is unavai-
lable immediately; moreover, clinical symptoms, visual
impairment, and mortality correlate closely to the degree
of metabolic acidosis rather than to serum methanol con-
centrations.4 The indications of ethanol or fomepizole
therapy are listed in Table 1 according to the guidelines of
the American Academy of Clinical Toxicology.4 Here, we
report the first pediatric case of methanol exposure to be
treated successfully with fomepizole in Taiwan.
Interestingly, the laboratory data of our patient were
not typical of those found in patients with methanol
poisoning, including high anion gap metabolic acidosis with
high osmolal gap. Osmolal gap is an important biomarker in
methanol poisoning, but its wide normal range makes it
insensitive to small concentrations of methanol.6 The
reference range of osmolal gap is from 0 mOsm/kg totion. (B) Level of serum bicarbonate over time after methanol
Table 1 Indications of ethanol or fomepizole therapy in
methanol poisoning.
Criteria
Documented plasma methanol concentration >20 mg/dL
or
Documented recent history of ingesting toxic amounts
of methanol and osmolal gap >10 mOsm/kg
or
History or strong clinical suspicion of methanol
poisoning and at least two of the following criteria:
(i) Arterial pH <7.3
(ii) Serum bicarbonate <20 mmol/L
(iii) Osmolal gap >10 mOsm/kg
Note. From “American academy of clinical toxicology practice
guidelines on the treatment of methanol poisoning,” by D.G.
Barceloux, G.R. Bond, E.P. Krenzelok, H. Cooper, and J.A. Vale.
2002, J Toxicol Clin Toxicol, 40, p. 428. Copyright 2002. Marcel
Dekker, Inc. Reprinted with permission.
Fomepizole in pediatric methanol exposure 35310 mOsm/kg in a healthy adult, and from 13.5 mOsm/kg
to 8.9 mOsm/kg in a healthy child.7 As a result, a normal
serum osmolal gap may be found in methanol poisoning in a
child whose baseline osmolal gap is very low or negative.
The increase of anion gap takes time because methanol
metabolizes to formic acid gradually.8 Our case was sent to
the emergency department 50 minutes after methanol
ingestion, thus serum anion gap may not have achieved a
significantly high level in that time. It has been proposed
that patients with methanol intoxication may present with
high osmolal gap or high anion gap; however, few cases
with osmolal gap and anion gap within the normal range
have been reported.8 In a study of toxicological case series
of preschool children, some patients with symptoms had a
negative serum methanol level.9 In our case, the father
witnessed the ingestion of alcohol paste, and its residue
was found in the patient’s mouth. Owing to the symptom of
decreased activity and severe metabolic acidosis, which is
most relevant to mortality of methanol poisoning, we
prescribed fomepizole according to the antidote
indication.
Ethanol is a traditional antidote for methanol intoxica-
tion. Oral ethanol is used as a temporizing antidote, and its
kinetics is unpredictable due to high variability in individual
metabolic rates and enteral absorption.10 Intravenous
ethanol is difficult to use because it requires central venous
access due to hyperosmolarity. The adverse effects include
hypoglycemia, hyponatremia, and cranial nervous systemTable 2 Reported cases of pediatric methanol poisoning with f
Refs Age, y Ingested substance
Brown et al12 5 Windshield washer fluid
De Brabander et al13 3 Pure methanol
Rozenfeld and Leikin5 16 Windshield washer fluid
Leonard and Akhtar14 4 “Blue Thunder” model engine
fuel (methanol and nitromethandepression. In addition, it requires intensive care and close
monitoring due to unstable serum ethanol concentration.2
Fomepizole was approved by the Food and Drug Admin-
istration (FDA) as an antidote for methanol poisoning in
2000.1 It has been regarded as a more potent and safer
antidote than ethanol. It is administrated conveniently via
a peripheral venous line. The recommended loading dose is
15 mg/kg over 30 minutes, followed by a maintenance dose
of 10 mg/kg every 12 hours for four doses. After 48 hours,
additional doses of 15 mg/kg every 12 hours are given if
necessary.1 It has been suggested to discontinue therapy
when the serum methanol concentration has decreased to
below 30 mg/dL. A median of four doses of fomepizole was
prescribed for methanol poisoning in prior clinical studies.1
Its adverse effects include headache, nausea, dizziness,
with rare reports of vomiting, seizure, and transient
elevation of hepatic aminotransferase levels.4,11 It is un-
necessary to monitor serum fomepizole concentration due
to its relative safety.1
The dosage regimen and clinical efficacy of fomepizole
use has been well established in adults; nevertheless, clin-
ical experience in pediatric patients is still limited. A review
article reported 14 cases of pediatric ethylene glycol,
diethylene glycol, butoxyethanol, and methanol poisoning
with fomepizole therapy, and only four cases were younger
than 2 years old, which highlights the limited data in the
pediatric population.3 We list an overview of all reported
cases of pediatric methanol poisoning with fomepizole
treatment in Table 2.5,12e14 Fomepizole was given with the
same dosage regimen as adults, and neither sequelae nor
adverse effects were observed. According to the Taiwan
antidote network, fomepizole is available in Taipei Veterans
General Hospital, China Medical University Hospital, Kaoh-
siung Medical University Hospital, Buddhist Tzu Chi General
Hospital, andChanghuaChristianHospital. The clinicians can
contact the nearest hospital to obtain fomepizole.
In addition to antidote administration, we should also
keep intravenous fluid supply to maintain adequate urine
output to enhance the excretion of methanol.2 Sodium bi-
carbonate administration is recommended for severe
acidemia (pH < 7.3).1 Hemodialysis should be considered
for significant metabolic acidosis (pH < 7.25e7.30), vision
impairment, unstable vital signs, renal failure, or electro-
lyte imbalance with poor response to treatment.4
In conclusion, fomepizole has been suggested to be an
efficacious and safe antidote for methanol intoxication in
adults, but there have been no reports in Asian children. In
our case, we prescribed fomepizole for a 1-year, 5-month-
old child with the dosage regimen the same as adults, and
metabolic acidosis improved quickly, without any adverseomepizole treatment.
Initial pH Initial bicarbonate,
mEq/L
Outcome Adverse
effects
7.43 23 Normal None
7.34 22 Normal None
7.38 19 Normal None
e)
Not reported Not reported Normal None
354 T.-H. Chen et aleffects or sequelae. Therefore, we report this successful
experience for pediatricians as a valuable case in toxico-
logical emergency.
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